Women who were postpartum with venous thromboembolism (VTE) or abnormal ECGs faced a substantially higher risk for pulmonary ...

Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year ...

Penumbra reported positive data for a trial of its treatment for pulmonary embolism. The use of computer-assisted vacuum thrombectomy resulted in improvements in thrombus burden reduction, heart rate, ...

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year—and kills about one in five high-risk patients, according to the American ...

The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 ...

Researchers have found that, in patients with pulmonary embolism, insurance status does not affect in-hospital mortality rates.

A woman who was in the hospital more than seven months ago and was in a coma for two days is sharing her story of survival after she suffered a massive blockage in her lungs that led to multiple organ ...

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Lecturio, the global digital healthcare education company, announced today the acquisition of SimTutor, a leading provider of interactive simulation-based tools ...

The landscape of coronary and pulmonary vascular medicine is undergoing a paradigm shift, fueled by breakthroughs in molecular biology, imaging, and ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.